Founded in 2006, the editors of the Orphanet Journal of Rare Diseases include professionals from hospital centers of excellence around the world such as Boston’s Children’s Hospital or the Mayo Clinic in the United States, the Peking Union Medical College Hospital in China, or the University Hospital of Lausanne of Switzerland, among others.

Since 2017, the Minority Diseases Group (MM) of the Bellvitge University Hospital (HUB) has established itself as a benchmark in the care of some 3,000 patients with more than 200 rare pathologies. Recognition as clinical experience units (UEC) of the Catalan Health Service in three large areas of the MM in recent months reinforces the care of these patients as one of the hospital’s priorities. On the other hand, the research group on Systemic and Vascular Diseases and Aging has consolidated and increased its scientific production.

Dr. Antoni Riera-Mestre is Head of the Internal Medicine Service at the HUB and head of the aforementioned IDIBELL group. He is the author of various publications in the field of rare diseases, professor at the Faculty of Medicine and Health Sciences of the University of Barcelona and has directed various doctoral theses, as well as coordinator of the Group of Rare Diseases of the Spanish Society of Internal Medicine (SEMI) during the period 2018-2022 and coordinator of the registry of patients with HHT called RiHHTa.